• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

tau 修饰谱可识别患者异质性和阿尔茨海默病的阶段。

Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease.

机构信息

F.M. Kirby Neurobiology Center, Department of Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

F.M. Kirby Neurobiology Center, Department of Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Cell. 2020 Dec 10;183(6):1699-1713.e13. doi: 10.1016/j.cell.2020.10.029. Epub 2020 Nov 13.

DOI:10.1016/j.cell.2020.10.029
PMID:33188775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8168922/
Abstract

To elucidate the role of Tau isoforms and post-translational modification (PTM) stoichiometry in Alzheimer's disease (AD), we generated a high-resolution quantitative proteomics map of 95 PTMs on multiple isoforms of Tau isolated from postmortem human tissue from 49 AD and 42 control subjects. Although Tau PTM maps reveal heterogeneity across subjects, a subset of PTMs display high occupancy and frequency for AD, suggesting importance in disease. Unsupervised analyses indicate that PTMs occur in an ordered manner, leading to Tau aggregation. The processive addition and minimal set of PTMs associated with seeding activity was further defined by analysis of size-fractionated Tau. To summarize, features in the Tau protein critical for disease intervention at different stages of disease are identified, including enrichment of 0N and 4R isoforms, underrepresentation of the C terminus, an increase in negative charge in the proline-rich region (PRR), and a decrease in positive charge in the microtubule binding domain (MBD).

摘要

为了阐明 Tau 异构体和翻译后修饰(PTM)化学计量在阿尔茨海默病(AD)中的作用,我们从 49 名 AD 患者和 42 名对照患者的死后组织中分离出 Tau 的多个异构体,生成了 Tau 上 95 种 PTM 的高分辨率定量蛋白质组图谱。尽管 Tau PTM 图谱在不同个体之间显示出异质性,但一组 PTMs 在 AD 中显示出高占有率和高频率,表明它们在疾病中很重要。无监督分析表明,PTMs 按顺序发生,导致 Tau 聚集。通过对大小分级的 Tau 进行分析,进一步定义了与成核活性相关的连续添加和最小 PTM 集。总之,确定了 Tau 蛋白中在疾病的不同阶段对疾病干预至关重要的特征,包括 0N 和 4R 异构体的富集、C 端的代表性降低、富含脯氨酸区域(PRR)的负电荷增加以及微管结合域(MBD)的正电荷减少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4341/8168922/09f764fefc9d/nihms-1639269-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4341/8168922/77340b63bb08/nihms-1639269-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4341/8168922/b1bf213d36d7/nihms-1639269-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4341/8168922/1874155519e9/nihms-1639269-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4341/8168922/55fa0a1c51e7/nihms-1639269-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4341/8168922/09f764fefc9d/nihms-1639269-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4341/8168922/77340b63bb08/nihms-1639269-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4341/8168922/b1bf213d36d7/nihms-1639269-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4341/8168922/1874155519e9/nihms-1639269-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4341/8168922/55fa0a1c51e7/nihms-1639269-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4341/8168922/09f764fefc9d/nihms-1639269-f0005.jpg

相似文献

1
Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease.tau 修饰谱可识别患者异质性和阿尔茨海默病的阶段。
Cell. 2020 Dec 10;183(6):1699-1713.e13. doi: 10.1016/j.cell.2020.10.029. Epub 2020 Nov 13.
2
Protein Semisynthesis Provides Access to Tau Disease-Associated Post-translational Modifications (PTMs) and Paves the Way to Deciphering the Tau PTM Code in Health and Diseased States.蛋白质半合成提供了获取与 Tau 疾病相关的翻译后修饰(PTMs)的途径,并为在健康和疾病状态下破译 Tau PTM 密码铺平了道路。
J Am Chem Soc. 2018 May 30;140(21):6611-6621. doi: 10.1021/jacs.8b02668. Epub 2018 May 21.
3
Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation.tau 双螺旋丝核形成基序中的翻译后修饰会破坏微管相互作用和寡聚物形成。
J Biol Chem. 2022 Jan;298(1):101442. doi: 10.1016/j.jbc.2021.101442. Epub 2021 Nov 24.
4
FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease.FLEXITau:体外及人类疾病中tau蛋白翻译后修饰的定量分析
Anal Chem. 2016 Apr 5;88(7):3704-14. doi: 10.1021/acs.analchem.5b04509. Epub 2016 Mar 7.
5
Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.Tau蛋白的翻译后修饰及其在阿尔茨海默病病理学中的作用。
Curr Alzheimer Res. 2024;21(1):24-49. doi: 10.2174/0115672050301407240408033046.
6
Quantification of Methylation and Phosphorylation Stoichiometry.定量甲基化和磷酸化计量。
Methods Mol Biol. 2024;2754:221-235. doi: 10.1007/978-1-0716-3629-9_13.
7
Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer's Disease Brain.阿尔茨海默病大脑中tau蛋白赖氨酸翻译后修饰的质谱分析
Methods Mol Biol. 2017;1523:161-177. doi: 10.1007/978-1-4939-6598-4_10.
8
Role of Post-translational Modifications in Alzheimer's Disease.翻译后修饰在阿尔茨海默病中的作用
Chembiochem. 2020 Apr 17;21(8):1052-1079. doi: 10.1002/cbic.201900573. Epub 2020 Jan 30.
9
Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry.通过质谱分析阿尔茨海默病的翻译后修饰。
Biochim Biophys Acta Mol Basis Dis. 2019 Aug 1;1865(8):2040-2047. doi: 10.1016/j.bbadis.2018.11.002. Epub 2018 Nov 24.
10
Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer's Disease and Other Tauopathies.翻译:翻译:tau 蛋白翻译后修饰和蛋白酶切割片段在阿尔茨海默病和其他 tau 病中的复杂作用。
Mol Neurobiol. 2024 Jul;61(7):4712-4731. doi: 10.1007/s12035-023-03867-x. Epub 2023 Dec 20.

引用本文的文献

1
The emerging roles of long non-coding RNAs in the nervous system.长链非编码RNA在神经系统中的新作用。
Nat Rev Neurosci. 2025 Sep 5. doi: 10.1038/s41583-025-00960-z.
2
O-GlcNAcylation-dependent liquid-liquid phase separation regulates the nuclear translocation of YAP to exacerbate vascular neointimal hyperplasia.O-连接的N-乙酰葡糖胺化依赖性液-液相分离调节YAP的核转位,从而加剧血管内膜增生。
Theranostics. 2025 Jul 11;15(16):7956-7972. doi: 10.7150/thno.113303. eCollection 2025.
3
Plasma tau biomarkers for biological staging of Alzheimer's disease.

本文引用的文献

1
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.血浆磷酸化 tau181 在阿尔茨海默病和额颞叶变性中的诊断价值。
Nat Med. 2020 Mar;26(3):387-397. doi: 10.1038/s41591-020-0762-2. Epub 2020 Mar 2.
2
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.阿尔茨海默病患者血浆 P-tau181:与其他生物标志物的关系、鉴别诊断、神经病理学和向阿尔茨海默病痴呆的纵向进展。
Nat Med. 2020 Mar;26(3):379-386. doi: 10.1038/s41591-020-0755-1. Epub 2020 Mar 2.
3
Cofactors are essential constituents of stable and seeding-active tau fibrils.
用于阿尔茨海默病生物学分期的血浆tau生物标志物。
Nat Aging. 2025 Aug 22. doi: 10.1038/s43587-025-00951-w.
4
Molecular Physiological and Pathological Progression of Neurological Diseases.神经疾病的分子生理与病理进展
Int J Mol Sci. 2025 Jul 23;26(15):7084. doi: 10.3390/ijms26157084.
5
An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease.阿尔茨海默病中淀粉样蛋白、tau蛋白和炎症病理生理学之间关系的综合观点。
Alzheimers Dement. 2025 Aug;21(8):e70404. doi: 10.1002/alz.70404.
6
Stoichiometric 14-3-3ζ binding promotes phospho-Tau microtubule dissociation and reduces aggregation and condensation.化学计量的14-3-3ζ结合促进磷酸化 Tau 与微管解离,并减少聚集和凝聚。
Commun Biol. 2025 Jul 31;8(1):1139. doi: 10.1038/s42003-025-08548-0.
7
Non-mutated human tau stimulates Alzheimer's disease-relevant neurodegeneration in a microglia-dependent manner.未发生突变的人类tau蛋白以小胶质细胞依赖的方式刺激与阿尔茨海默病相关的神经退行性变。
Sci Rep. 2025 Jul 29;15(1):27664. doi: 10.1038/s41598-025-12869-9.
8
Spatially constrained disulfide bond shuffling delays insulin aggregation and enhances neurotoxicity.空间受限的二硫键重排延缓胰岛素聚集并增强神经毒性。
Nat Commun. 2025 Jul 25;16(1):6841. doi: 10.1038/s41467-025-62257-0.
9
Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer's disease spectrum.大脑中的异构化β淀粉样蛋白(Aβ)能够区分阿尔茨海默病谱系中淀粉样变性的状态。
Acta Neuropathol. 2025 Jul 22;150(1):7. doi: 10.1007/s00401-025-02914-2.
10
Performance of novel tau antibodies across multiple modalities for Alzheimer's disease assessment.新型tau抗体在多种模式下用于阿尔茨海默病评估的性能
Alzheimers Dement. 2025 Jul;21(7):e70481. doi: 10.1002/alz.70481.
辅助因子是稳定和具有成核活性的 tau 纤维的必需组成部分。
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):13234-13239. doi: 10.1073/pnas.1810058115. Epub 2018 Dec 11.
4
Tau filaments from multiple cases of sporadic and inherited Alzheimer's disease adopt a common fold.来自多个散发性和遗传性阿尔茨海默病病例的 Tau 纤维采用一种常见的折叠方式。
Acta Neuropathol. 2018 Nov;136(5):699-708. doi: 10.1007/s00401-018-1914-z. Epub 2018 Oct 1.
5
Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease.阿尔茨海默病大脑泛素组的定量分析。
Proteomics. 2018 Oct;18(20):e1800108. doi: 10.1002/pmic.201800108.
6
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.阿尔茨海默病三转基因小鼠模型中改变的蛋白质 O-GlcNAc 修饰的蛋白质组学鉴定。
Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3309-3321. doi: 10.1016/j.bbadis.2018.07.017. Epub 2018 Jul 18.
7
Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls.tau 免疫疗法治疗阿尔茨海默病和相关 tau 病:进展和潜在陷阱。
J Alzheimers Dis. 2018;64(s1):S555-S565. doi: 10.3233/JAD-179937.
8
How many human proteoforms are there?人类蛋白异构体有多少?
Nat Chem Biol. 2018 Feb 14;14(3):206-214. doi: 10.1038/nchembio.2576.
9
What is the evidence that tau pathology spreads through prion-like propagation?tau 病理学是否通过类朊病毒传播而扩散的证据是什么?
Acta Neuropathol Commun. 2017 Dec 19;5(1):99. doi: 10.1186/s40478-017-0488-7.
10
RNA stores tau reversibly in complex coacervates.RNA以可逆方式将tau储存在复合凝聚物中。
PLoS Biol. 2017 Jul 6;15(7):e2002183. doi: 10.1371/journal.pbio.2002183. eCollection 2017 Jul.